PBMC Humanized Mice
Supporting Preclinical In Vivo Studies
PBMC Humanized Mice Accelerate Drug Discovery and Development
Pre-clinical evaluation is a common and necessary step in the drug development process facilitating the evaluation of both the efficacy and toxicity of compounds in a living system. Utilizing PBMC humanized mice that most closely mimic the human immune system has become an industry standard particularly for immuno-oncology and cell therapy.
Prediction of therapeutic efficacy and success is more accurate when using such models and should be a cornerstone of your cell and gene therapy in vivo testing program. HemaCare and Charles River Laboratories have partnered to provide you with the tools you need to efficiently incorporate humanization studies into your workflow.